-
1 Comment
Integra LifeSciences Holdings Corporation is currently in a long term uptrend where the price is trading 9.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
Integra LifeSciences Holdings Corporation's total revenue sank by 1.6% to $389M since the same quarter in the previous year.
Its net income has increased by 505.4% to $93M since the same quarter in the previous year.
Finally, its free cash flow grew by 7.2% to $72M since the same quarter in the previous year.
Based on the above factors, Integra LifeSciences Holdings Corporation gets an overall score of 4/5.
Sector | Healthcare |
---|---|
Exchange | F |
CurrencyCode | EUR |
ISIN | US4579852082 |
Industry | Medical Devices |
Beta | 1.27 |
---|---|
Market Cap | 1B |
PE Ratio | None |
Target Price | 77.7 |
Dividend Yield | None |
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IL3.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025